EDIT
Editas Medicine, Inc.NASDAQHealthcare$2.67+1.87%ClosedMarket Cap: $261.3M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
8.85
P/S
6.57
EV/EBITDA
-1.32
DCF Value
$-5.57
FCF Yield
-62.3%
Div Yield
0.0%
Margins & Returns
Gross Margin
100.0%
Operating Margin
-410.3%
Net Margin
-395.0%
ROE
-523.3%
ROA
-85.8%
ROIC
-109.9%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $24.7M | 100.0% | $-14.0M | $-5.6M | $-0.06 | — |
| FY 2025 | $40.5M | 100.0% | $-99.3M | $-160.1M | $-1.80 | — |
| Q3 2025 | $7.5M | 100.0% | $-24.5M | $-25.1M | $-0.28 | — |
| Q2 2025 | $3.6M | 100.0% | $-51.5M | $-53.2M | $-0.63 | — |
| Q1 2025 | $4.7M | 100.0% | $-76.2M | $-76.1M | $-0.92 | — |
| Q4 2024 | $30.6M | 100.0% | $-46.6M | $-45.4M | $-0.55 | — |
| FY 2024 | $32.3M | 100.0% | $-251.2M | $-237.1M | $-2.88 | — |
| Q3 2024 | $61.0K | -2521.3% | $-65.7M | $-62.1M | $-0.75 | — |
| Q2 2024 | $513.0K | -176.8% | $-71.9M | $-67.6M | $-0.82 | — |
| Q1 2024 | $1.1M | -24.1% | $-67.0M | $-62.0M | $-0.76 | — |
| Q4 2023 | $60.0M | 97.6% | $-24.0M | $-18.9M | $-0.23 | — |
| FY 2023 | $78.1M | 92.2% | $-169.2M | $-153.2M | $-2.02 | — |